9Vote!
SeekingAlpha.com (Free subscription) | 10/18/2009
AlphaClone submits: The founders of the Galleon Group , a hedge fund started in 1997 and which has a technology and healthcare focus, have been charged with insider trading . Galleon is one of the 250 hedge and institutional investment funds that are available on AlphaClone. The fund's Top 10 Holding Clone , which invests quarterly in the the fund's ten largest holdings at the time they are disclosed,...
Explore : Abercrombie and Fitch,
Alcon Inc.,
Apparel,
Apparel Stores,
Apple Inc.,
Biogen Idec Inc.,
Biotechnologies,
Business,
CommScope Inc.,
Computer industry,
Conglomerates,
Consumer Electronics,
Dell Inc.,
Drug Manufacturers,
eBay,
Electronic Arts Inc.,
Electronic Commerce,
F5 Networks Inc.,
Fashion Industry,
Finance,
Google Inc.,
GPS,
Health Industries,
Hedge funds,
Hewlett Packard Company,
Investors,
Online auction,
PepsiCo Inc.,
QUALCOMM Inc,
Qualcomm Inc.,
Research in Motion Ltd.,
Retailers,
Search Engines,
Software industry,
Technology,
Telecommunication,
Telecommunication Companies,
Teradyne Inc.,
The Gap Inc.,
Tyco International Ltd,
Verisign Inc.,
Video Games Industry,
Yahoo! Inc.
6Vote!
iStockAnalyst.com (Free subscription) | 10/05/2009
One of the well known makers of the Botox wrinkle treatment, Allergan Inc, has gathered its courage and challenged the government's ban on off-label drug marketing to doctors. [More...]
1Vote!
HAPPI Breaking News (Free subscription) | 08/04/2009
The Food and Drug Administration (FDA) approved a new warning on Allergan Inc.'s Botox and a similar product about the possibility of life-threatening breathing and swallowing problems, according to recent reports. This follows an earlier advisement about stronger warnings. Along with signing off on a boxed warning for Botox and Myobloc, made by Solstice Neurosciences Inc., the agency said it was...
5Vote!
The Los Angeles Business (Free subscription) | 07/31/2009
Despite a slip in overall revenue, especially in sales from its signature product Botox, Allergan Inc. recorded an increase in profits for the second quarter on Friday. (AGN)
4Vote!
Market Watch (Free subscription) | 07/31/2009
BOSTON (MarketWatch) -- Drug stocks inched higher in early trading Friday as shares of Allergan Inc. gained after it issued a positive second-quarter earnings report. The NYSE Arca Pharmaceutical Index and the NYSE Arca Biotechnology Index were both up marginally at 281.14 and 879.47, respectively. Shares of Botox-maker Allergan were up 3% at $54.14. Market Pulse Stories are Rapid-fire, short news...
4Vote!
Market Wire (Free subscription) | 07/30/2009
HONG KONG (MARKET WIRE) Paragon is pleased to announce that its latest earnings analysis can be found in its Market News Update section of the website for Dryships Inc. (NASDAQ: DRYS), Chevron Corporation (NYSE: CVX), Dominion Resources (NYSE: D), and Allergan Inc (NYSE: AGN) has been released.
4Vote!
Daily Advance - Business (Free subscription) | 07/23/2009
IRVINE, Calif. — Allergan Inc., which makes eye-care products and Botox, said Thursday it rece...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS.
Two days later I was BLIND
Use Google and enter EPOCRATES...
anonymous - 07/26/2009
5Vote!
Miami Herald (Free subscription) | 07/23/2009
Allergan Inc., which makes eye-care products and Botox, said Thursday it received Food and Drug Administration approval for its post-cataract surgery eye solution Acuvail.
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamthasone) drops by ALCON LABS.
Two days later I was BLIND
Use Google and enter EPOCRATES...
anonymous - 07/26/2009
6Vote!
Seattle Times (Free subscription) | 07/23/2009
Allergan Inc., which makes eye-care products and Botox, said Thursday it received Food and Drug Administration approval for its post-cataract surgery eye solution Acuvail.
Click here to see all comments
MAXIDEX DEXMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS.
Two days later I was BLIND
Use Google and enter EPOCRATES...
anonymous - 07/26/2009
5Vote!
Seattle Post-Intelligencer (Free subscription) | 07/23/2009
IRVINE, Calif. -- Allergan Inc., which makes eye-care products and Botox, said Thursday it received Food and Drug Administration approval for its post-cataract surgery eye solution Acuvail.
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS.
Two days later I was BLIND
Use Google and enter EPOCRATES...
anonymous - 07/26/2009
3Vote!
dBTechno (Free subscription) | 07/21/2009
Boston (DbTechNo) - The Food and Drug Administration (FDA) have just announced that they have given fast track status to a cancer drug made by both Spectrum Pharmaceuticals Inc. and Allergan Inc. Their drug, EOquin, has been designed to treat patients diagnosed with non-muscle invasive bladder cancer. The drug is meant for those patients whose cancer has [...]
1Vote!
Market Wire (Free subscription) | 07/17/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Canadian Pacific Railway Limited (NYSE: CP), EOG Resources Inc. (NYSE: EOG), Genworth Financial Inc. (NYSE: GNW), Allergan...
5Vote!
The Los Angeles Business (Free subscription) | 06/18/2009
The U.S. Food and Drug Administration has approved Allergan Inc.'s Ozurdex treatment for the retinal disease macular edema. (AGN)
4Vote!
Market Watch (Free subscription) | 06/18/2009
BOSTON (MarketWatch) -- Allergan Inc. said Thursday that it has won U.S. regulatory approval for its eye treatment Ozurdextm. The biodegradable implant is used to treat macular edema, a type of swelling of the retina, due to the eye conditions branch retinal vein occlusion, or BRVO, or central retinal vein occlusion, also known as CRVO. If untreated, the BRVO and CRVO can lead to vision loss. Market...
Videos